
Christian C. Boesen
Examiner (ID: 11357, Phone: (571)270-1321 , Office: P/1639 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 4131, 1675, 1636, 1639, 1684 |
| Total Applications | 995 |
| Issued Applications | 677 |
| Pending Applications | 91 |
| Abandoned Applications | 262 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16392414
[patent_doc_number] => 20200333355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => METHODS OF VIRAL NEUTRALIZING ANTIBODY EPITOPE MAPPING
[patent_app_type] => utility
[patent_app_number] => 16/922935
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922935 | Methods of viral neutralizing antibody epitope mapping | Jul 6, 2020 | Issued |
Array
(
[id] => 16391339
[patent_doc_number] => 20200332280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => USE OF LAMBDA-GAM PROTEIN IN RIBOSOMAL DISPLAY TECHNOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/920247
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920247
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/920247 | USE OF LAMBDA-GAM PROTEIN IN RIBOSOMAL DISPLAY TECHNOLOGY | Jul 1, 2020 | Abandoned |
Array
(
[id] => 19441532
[patent_doc_number] => 12091776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Protease activity profiling via programmable phage display of comprehensive proteome-scale peptide libraries
[patent_app_type] => utility
[patent_app_number] => 16/913572
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 26
[patent_no_of_words] => 16305
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913572 | Protease activity profiling via programmable phage display of comprehensive proteome-scale peptide libraries | Jun 25, 2020 | Issued |
Array
(
[id] => 17777011
[patent_doc_number] => 20220243360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PEPTIDE LIBRARIES HAVING ENHANCED SUBSEQUENCE DIVERSITY AND METHODS FOR USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/622479
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622479 | Peptide libraries having enhanced subsequence diversity and methods for use thereof | Jun 25, 2020 | Issued |
Array
(
[id] => 18153381
[patent_doc_number] => 11566346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Protein scaffold
[patent_app_type] => utility
[patent_app_number] => 16/911398
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 22860
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16911398
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/911398 | Protein scaffold | Jun 24, 2020 | Issued |
Array
(
[id] => 19211014
[patent_doc_number] => 12000064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Universal reporter cell assay for specificity test of novel antigen binding moieties
[patent_app_type] => utility
[patent_app_number] => 16/906778
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 44
[patent_no_of_words] => 35601
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906778 | Universal reporter cell assay for specificity test of novel antigen binding moieties | Jun 18, 2020 | Issued |
Array
(
[id] => 18701704
[patent_doc_number] => 11788205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Car-t cell assay for specificity test of novel antigen binding moieties
[patent_app_type] => utility
[patent_app_number] => 16/906931
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 27939
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906931
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906931 | Car-t cell assay for specificity test of novel antigen binding moieties | Jun 18, 2020 | Issued |
Array
(
[id] => 16391341
[patent_doc_number] => 20200332282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => VISUAL CONTINUOUS SPATIAL DIRECTED EVOLUTION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/904549
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904549 | Visual continuous spatial directed evolution method | Jun 16, 2020 | Issued |
Array
(
[id] => 18685525
[patent_doc_number] => 11781248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Anti-TALEN antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/900602
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17012
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900602
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900602 | Anti-TALEN antibodies and uses thereof | Jun 11, 2020 | Issued |
Array
(
[id] => 16711919
[patent_doc_number] => 20210079066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => RADICALLY DIVERSE HUMAN ANTIBODY LIBRARY
[patent_app_type] => utility
[patent_app_number] => 16/899519
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899519 | RADICALLY DIVERSE HUMAN ANTIBODY LIBRARY | Jun 10, 2020 | Abandoned |
Array
(
[id] => 16525705
[patent_doc_number] => 20200399785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR3 DESIGNS
[patent_app_type] => utility
[patent_app_number] => 16/897069
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897069
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897069 | Libraries of genetic packages comprising novel HC CDR3 designs | Jun 8, 2020 | Issued |
Array
(
[id] => 18779116
[patent_doc_number] => 11820810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Antibodies, variable domains and chains tailored for human use
[patent_app_type] => utility
[patent_app_number] => 16/886394
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 60951
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886394 | Antibodies, variable domains and chains tailored for human use | May 27, 2020 | Issued |
Array
(
[id] => 18504960
[patent_doc_number] => 11702765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Recombinant fusion proteins and libraries from immune cell repertoires
[patent_app_type] => utility
[patent_app_number] => 16/886612
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19804
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886612
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886612 | Recombinant fusion proteins and libraries from immune cell repertoires | May 27, 2020 | Issued |
Array
(
[id] => 16361000
[patent_doc_number] => 20200317751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Antibodies, Variable Domains and Chains Tailored for Human Use
[patent_app_type] => utility
[patent_app_number] => 16/886057
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886057 | Antibodies, Variable Domains and Chains Tailored for Human Use | May 27, 2020 | Abandoned |
Array
(
[id] => 18420585
[patent_doc_number] => 20230175047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => ARRAY AND METHOD FOR DETECTING SPATIAL INFORMATION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/611099
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611099 | Array and method for detecting spatial information of nucleic acids | May 13, 2020 | Issued |
Array
(
[id] => 17762661
[patent_doc_number] => 20220236273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => METHOD OF SCREENING FOR PEPTIDES CAPABLE OF BINDING TO A UBIQUITIN PROTEIN LIGASE (E3)
[patent_app_type] => utility
[patent_app_number] => 17/610593
[patent_app_country] => US
[patent_app_date] => 2020-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610593 | Method of screening for peptides capable of binding to a ubiquitin protein ligase (E3) | May 12, 2020 | Issued |
Array
(
[id] => 18504961
[patent_doc_number] => 11702766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Systematic creation of fluorescent fusion polypeptides
[patent_app_type] => utility
[patent_app_number] => 15/931154
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1833
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931154 | Systematic creation of fluorescent fusion polypeptides | May 12, 2020 | Issued |
Array
(
[id] => 18153382
[patent_doc_number] => 11566347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Antibody variants
[patent_app_type] => utility
[patent_app_number] => 15/930225
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 8468
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930225
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930225 | Antibody variants | May 11, 2020 | Issued |
Array
(
[id] => 20622886
[patent_doc_number] => 12590386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Recombinant polyclonal proteins and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/607497
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24647
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607497 | Recombinant polyclonal proteins and methods of use thereof | Apr 29, 2020 | Issued |
Array
(
[id] => 18315363
[patent_doc_number] => 11629434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Antibody screening methods
[patent_app_type] => utility
[patent_app_number] => 16/862851
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 8036
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862851 | Antibody screening methods | Apr 29, 2020 | Issued |